The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(4-chlorophenyl)-3-(2-methyl-4-((6-(methylamino)pyrimidin-4-yl)oxy)phenyl)urea ID: ALA4096368
PubChem CID: 137655533
Max Phase: Preclinical
Molecular Formula: C19H18ClN5O2
Molecular Weight: 383.84
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CNc1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)cc3)c(C)c2)ncn1
Standard InChI: InChI=1S/C19H18ClN5O2/c1-12-9-15(27-18-10-17(21-2)22-11-23-18)7-8-16(12)25-19(26)24-14-5-3-13(20)4-6-14/h3-11H,1-2H3,(H,21,22,23)(H2,24,25,26)
Standard InChI Key: WEZBUZDHZHQDGE-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
6.7672 -8.3039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7661 -9.1235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4741 -9.5324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1838 -9.1230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1810 -8.3003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4723 -7.8951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0581 -9.5315 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3507 -9.1224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6426 -9.5304 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3513 -8.3052 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9353 -9.1212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9407 -8.3031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2341 -7.8940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5251 -8.3021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5271 -9.1235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2342 -9.5289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8871 -7.8891 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.5964 -8.2950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5961 -9.1099 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.3045 -9.5157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0117 -9.1044 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0060 -8.2830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2970 -7.8809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7107 -7.8693 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.4213 -8.2727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8172 -7.8939 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
7.4739 -10.3496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
7 8 1 0
8 9 1 0
8 10 2 0
9 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
5 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
22 24 1 0
24 25 1 0
14 26 1 0
3 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 383.84Molecular Weight (Monoisotopic): 383.1149AlogP: 4.92#Rotatable Bonds: 5Polar Surface Area: 88.17Molecular Species: NEUTRALHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.66CX Basic pKa: 4.78CX LogP: 4.47CX LogD: 4.47Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.58Np Likeness Score: -1.92
References 1. Chen Y, Zheng Y, Jiang Q, Qin F, Zhang Y, Fu L, He G.. (2017) Integrated bioinformatics, computational and experimental methods to discover novel Raf/extracellular-signal regulated kinase (ERK) dual inhibitors against breast cancer cells., 127 [PMID:27839788 ] [10.1016/j.ejmech.2016.11.009 ]